Primary Sclerosing Cholangitis
GPTKB entity
Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
disease
|
| gptkbp:advertising |
health organizations
patient advocacy groups medical conferences |
| gptkbp:ageLimit |
typically diagnosed in 30s to 50s
|
| gptkbp:associatedWith |
ulcerative colitis
|
| gptkbp:clinicalTrials |
ongoing studies
biologics new therapies immunosuppressants |
| gptkbp:demographics |
rare
|
| gptkbp:diseaseResistance |
gptkb:ERCP
MRI |
| gptkbp:firstDescribedBy |
1970s
|
| gptkbp:gender |
more common in males
|
| gptkbp:geneticDiversity |
HLA-B8
HLA-DR2 |
| gptkbp:hasCapacity |
counseling services
educational resources support groups |
| gptkbp:historicalSignificance |
increased research interest
better understanding of liver diseases improved diagnostic techniques |
| https://www.w3.org/2000/01/rdf-schema#label |
Primary Sclerosing Cholangitis
|
| gptkbp:impact |
liver transplant
medications bile ducts |
| gptkbp:is_a_route_for |
autoimmune process
|
| gptkbp:personalLife |
regular monitoring
exercise recommendations diet changes |
| gptkbp:relatedPatent |
Crohn's disease
liver cancer gallstones bile duct cancer cholangiocarcinoma autoimmune hepatitis primary biliary cholangitis |
| gptkbp:researchFocus |
long-term outcomes
treatment options understanding etiology |
| gptkbp:riskManagement |
family history
smoking exposure to certain chemicals |
| gptkbp:symptoms |
fatigue
abdominal pain jaundice itching |